PortfoliosLab logoPortfoliosLab logo
BIIB vs. UPRO
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

BIIB vs. UPRO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Biogen Inc. (BIIB) and ProShares UltraPro S&P 500 (UPRO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BIIB achieves a 18.44% return, which is significantly lower than UPRO's 33.75% return. Over the past 10 years, BIIB has underperformed UPRO with an annualized return of -4.07%, while UPRO has yielded a comparatively higher 29.22% annualized return.


BIIB

1D
3.29%
1M
-3.55%
6M
17.93%
YTD
18.44%
1Y
57.68%
3Y*
-8.14%
5Y*
-9.14%
10Y*
-4.07%
ALL TIME*
12.93%

UPRO

1D
5.34%
1M
9.50%
6M
30.93%
YTD
33.75%
1Y
61.82%
3Y*
49.06%
5Y*
20.91%
10Y*
29.22%
ALL TIME*
33.82%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$236.59M$290.29M$254.85M
$337.28M$304.70M$362.53M

BIIB vs. UPRO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BIIB
Biogen Inc.
18.44%15.09%-40.91%-6.55%15.42%-2.02%-17.48%-1.39%-5.54%12.34%
UPRO
ProShares UltraPro S&P 500
33.75%31.88%63.57%68.53%-56.84%98.64%10.09%102.30%-25.11%71.37%

Correlation

The correlation between BIIB and UPRO is 0.09, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.09

Correlation (3Y)
Balances recent behavior with more history.

0.26

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.38

Correlation (10Y)
Provides a long-term view across more market conditions.

0.41

Correlation (All Time)
Calculated using the full available price history since Jun 25, 2009

0.46

Over the past year, the correlation between BIIB and UPRO has dropped to 0.09 - well below their long-term average of 0.46, suggesting their price drivers have been diverging.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BIIB vs. UPRO — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

BIIB
BIIB Risk / Return Rank: 8686
Overall Rank
BIIB Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
BIIB Sortino Ratio Rank: 8484
Sortino Ratio Rank
BIIB Omega Ratio Rank: 8181
Omega Ratio Rank
BIIB Calmar Ratio Rank: 9292
Calmar Ratio Rank
BIIB Martin Ratio Rank: 9090
Martin Ratio Rank

UPRO
UPRO Risk / Return Rank: 5959
Overall Rank
UPRO Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
UPRO Sortino Ratio Rank: 5454
Sortino Ratio Rank
UPRO Omega Ratio Rank: 5454
Omega Ratio Rank
UPRO Calmar Ratio Rank: 5858
Calmar Ratio Rank
UPRO Martin Ratio Rank: 6666
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

BIIB vs. UPRO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Biogen Inc. (BIIB) and ProShares UltraPro S&P 500 (UPRO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BIIBUPRODifference
Sharpe ratioReturn per unit of total volatility

+0.01

Sortino ratioReturn per unit of downside risk

+0.25

Omega ratioGain probability vs. loss probability

1.28

1.27

+0.01

Calmar ratioReturn relative to maximum drawdown

4.04

2.32

+1.72

Martin ratioReturn relative to average drawdown

9.81

8.87

+0.94

BIIB vs. UPRO - Sharpe Ratio Comparison

The current BIIB Sharpe Ratio is 1.62, which is comparable to the UPRO Sharpe Ratio of 1.62. The chart below compares the historical Sharpe Ratios of BIIB and UPRO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BIIB vs. UPRO - Drawdown Comparison

The maximum BIIB drawdown since its inception was -89.98%, which is greater than UPRO's maximum drawdown of -76.82%. Use the drawdown chart below to compare losses from any high point for BIIB and UPRO.


Loading charts...

Drawdown Indicators


BIIBUPRODifference

Max Drawdown

Largest peak-to-trough decline

-89.98%

-76.82%

-13.16%

Max Drawdown (1Y)

Largest decline over 1 year

-14.34%

-26.78%

+12.44%

Max Drawdown (3Y)

Largest decline over 3 years

-58.64%

-48.87%

-9.77%

Max Drawdown (5Y)

Largest decline over 5 years

-67.59%

-63.94%

-3.65%

Max Drawdown (10Y)

Largest decline over 10 years

-72.66%

-76.82%

+4.16%

Current Drawdown

Current decline from peak

-56.21%

0.00%

-56.21%

Average Drawdown

Average peak-to-trough decline

-36.70%

-14.34%

-22.36%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.90%

6.99%

-1.09%

Volatility

BIIB vs. UPRO - Volatility Comparison

Biogen Inc. (BIIB) has a higher volatility of 14.40% compared to ProShares UltraPro S&P 500 (UPRO) at 12.34%. This indicates that BIIB's price experiences larger fluctuations and is considered to be riskier than UPRO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BIIBUPRODifference

Volatility (1M)

Calculated over the trailing 1-month period

14.40%

12.34%

+2.06%

Volatility (6M)

Calculated over the trailing 6-month period

27.45%

30.99%

-3.54%

Volatility (1Y)

Calculated over the trailing 1-year period

35.71%

38.70%

-2.99%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

34.65%

50.79%

-16.14%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

41.36%

53.83%

-12.47%

Dividends

BIIB vs. UPRO - Dividend Comparison

BIIB has not paid dividends to shareholders, while UPRO's dividend yield for the trailing twelve months is around 0.70%.


PositionTTM20252024202320222021202020192018201720162015
BIIB
Biogen Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
UPRO
ProShares UltraPro S&P 500
0.70%0.84%0.93%0.74%0.52%0.06%0.11%0.41%0.63%0.00%0.12%0.34%

Frequently Asked Questions


BIIB and UPRO have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BIIB has higher volatility (14.40%) compared to UPRO (12.34%). In terms of maximum drawdown, BIIB dropped -89.98% vs UPRO's -76.82%.

BIIB currently has the higher Sharpe Ratio (1.62 vs 1.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BIIB and UPRO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer